Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparing ATG-Fresenius vs Thymoglobulin for the Prevention of Graft-versus-host Disease in the Setting of Haplo-identical Hematopoietic Stem Cell Transplantation

NCT03631563 is registered in ClinicalTrials.gov with Fujian Medical University as lead sponsor.

NCT NCT03631563
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03631563 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparing ATG-Fresenius vs Thymoglobulin for the Prevention of Graft-versus-host Disease in the Setting of Haplo-identical Hematopoietic Stem Cell Transplantation
Lead sponsor
Fujian Medical University
Phase
Phase 2/3
Overall status
Unknown status
Start date
March 1, 2013
Completion date
December 1, 2020
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gvhd in the setting of haplo-hsct